| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |